Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection

Richard A. Colvin*, Tawesak Tanwandee, Teerha Piratvisuth, Satawat Thongsawat, Aric Josun Hui, Hongfei Zhang, Hong Ren, Pei Jer Chen, Wan Long Chuang, Abhasnee Sobhonslidsuk, Ruobing Li, Yin Qi, Jens Praestgaard, Yi Han, Junfang Xu, Daniel S. Stein, Rong Nan Chien, Robert Flisiak, Maciej Jablkowski, Yun Fan LiawJoseph Jao Yiu Sung

*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science